{"id":"NCT00124735","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)","officialTitle":"An Open-label, Randomized, Phase IIIB, Multicenter Trial to Evaluate the Pharmacodynamic Parameters of Intubation Bolus, and Bolus and Infusion Maintenance Doses of Zemuron® in Pediatric and Adolescent Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2007-08","completion":"2007-09","firstPosted":"2005-07-28","resultsPosted":"2009-04-15","lastUpdate":"2016-08-24"},"enrollment":149,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anesthesia"],"interventions":[{"type":"DRUG","name":"Rocuronium bolus maintenance","otherNames":["Zemuron","ORG 9426"]},{"type":"DRUG","name":"rocuronium continuous infusion maintenance","otherNames":["Zemuron","ORG 9426"]}],"arms":[{"label":"Rocuronium bolus maintenance","type":"EXPERIMENTAL"},{"label":"Rocuronium continuous infusion maintenance","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to determine the dose requirements of rocuronium bromide when administered as a bolus dose (a single, large dose) for intubation (insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation) and when administered by either continuous infusion or bolus doses for maintenance of muscle relaxation in term neonates (birth to \\<28 days old), infants (28 days to \\<=3 months) and toddlers (\\>3 months to \\<=2 years), children (2 years to less than or equal to 11 years of age), and adolescents (\\>11 years to less than or equal to 17 years of age).","primaryOutcome":{"measure":"Total Dose of Zemuron (Rocuronium) Administered","timeFrame":"during surgery","effectByArm":[{"arm":"Rocuronium Bolus Maintenance - Neonate (BN)","deltaMin":0.91,"sd":0.17},{"arm":"Rocuronium Bolus Maintenance - Infants (BI)","deltaMin":0.78,"sd":0.07},{"arm":"Rocuronium Bolus Maintenance - Toddlers (BT)","deltaMin":0.86,"sd":0.18},{"arm":"Rocuronium Bolus Maintenance -Children (BC)","deltaMin":0.81,"sd":0.1},{"arm":"Rocuronium Bolus Maintenance - Adolescents (BA)","deltaMin":0.96,"sd":0.16},{"arm":"Rocuronium Continuous Infusion Maintenance - Neonates (IN)","deltaMin":1.01,"sd":0.37},{"arm":"Rocuronium Continuous Infusion Maintenance - Infants (II)","deltaMin":0.84,"sd":0.15},{"arm":"Rocuronium Continuous Infusion Maintenance - Toddlers (IT)","deltaMin":1,"sd":0.25},{"arm":"Rocuronium Continuous Infusion Maintenance - Children (IC)","deltaMin":1.26,"sd":0.78},{"arm":"Rocuronium Continuous Infusion Maintenance - Adolescents (IA)","deltaMin":0.99,"sd":0.37}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":64},"commonTop":["procedural pain"]}}